All In MedTech

FDA Clearance Tracker · P990009-S002

FLOSEAL MATRIX HEMOSTATIC SEALANT

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 12, 2000 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 12, 2000

Approved

Time to decision

49 days

Received Oct 24, 2000. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P990009-S002
Device name
FLOSEAL MATRIX HEMOSTATIC SEALANT
Applicant location
Round Lake, IL
Received
Oct 24, 2000
Decided
Dec 12, 2000
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P990009

Device type

Device class
Class III
Regulation
21 CFR 878.4490

Every decision under product code LMF

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A LABELING CHANGE.

Source documents

Other decisions for Baxter Healthcare Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

3 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.